|
SkyePharma's Asthma Treatment Faces European Approval Delay; Shares Fall
RTT News PK: News ) plunged on the London Stock Exchange in Tuesday morning trade, after the British drug delivery specialist reported a delay in review of the European Marketing Authorisation Application or MAA for its asthma therapy Flutiform due to lack of … SkyePharma lung drug faces European approval delay |
View full post on asthma – Google News